In vivo platelet deposition on polytetrafluoroethylene coated with fibrin glue containing fibroblast growth factor 1 and heparin in a canine model☆☆☆
Abstract
Background: We previously reported that the coating of expanded polytetrafluoroethylene (ePTFE) with fibrin glue containing fibroblast growth factor 1 (FGF-1) and heparin accelerates endothelial coverage of grafts implanted into animals. We report here the effect of this surface modification on early platelet deposition.
Materials and methods: Nine dogs received 7-cm ePTFE grafts, 60-μm internodal distance, 4-mm internal diameter, as bilateral aortoiliac implants, one coated (luminal cross section and abluminal surface) with fibrin glue (fibrinogen 32.1 mg/mL, thrombin 0.32 U/mL) containing FGF-1 (11 ng/mL) and heparin (250 U/mL), the other uncoated. After 5, 30, or 120 minutes of circulation with blood containing autologous platelets radiolabeled with indium 111, γ emissions were quantitated on explants and correlated to surface areas measured by computerized planimetry.
Results: Both global and segmental comparisons showed significantly (P <0.05, Student's t-test) less platelet deposition on coated than on uncoated grafts after 120 minutes of circulation, but no difference at 5 and 30 minutes.
Conclusions: In this model, ePTFE coating with fibrin glue containing FGF-1 and heparin shows no adverse effect on early platelet deposition.
No full text is available. To read the body of this article, please view the PDF online.
To access this article, please choose from the options below
☆ Supported by grant RO1 HL41272 from the National Institutes of Health.Dr. Gosselin is supported by a grant from the R. Samuel McLaughlin Foundation, Toronto, Canada.
☆☆ Presented at the 23rd Annual Meeting of The Society for Clinical Vascular Surgery, Fort Lauderdale, Florida, March 22–26, 1995.
PII: S0002-9610(99)80270-0
© 1995 Published by Elsevier Inc.
